Fecal microbiota transplantation vs control
Serious adverse events · adults with recurrent Clostridioides difficile infection (rCDI)
Summary of findings table ‐ Fecal microbiota transplantation (FMT) showed no clear difference in serious adverse events compared with control (moderate certainty).
1 finding from 1 review
- Fecal microbiota transplantation for the treatment of recurrent Clostridioides difficile (Clostridium difficile) 2023 · Cochrane Headline outcomes onlyRR 0.73 [0.38, 1.41]6 studies · 320 participantsModerate